Skip to main content
Log in

Brain Metastases in Colorectal Cancers

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Although colorectal cancer is the most common cancer in Singapore, brain metastases associated with colorectal primaries are quite rare, with reported incidences ranging from less than 1% to 4%. This is a review of the incidence, presentation, and prognosis of brain secondaries from colorectal primaries in our institution.

Methods

From a prospectively collected database, 4378 patients underwent surgery for colorectal cancers between 1995 and 2003. Patients who developed brain metastases were identified and their records reviewed retrospectively.

Results

Twenty-seven patients who developed brain metastases were identified, for an incidence of 0.62%. Seventy-one percent of the patients had a tumor in the rectum or sigmoid; 92.6% of patients had metachronous brain secondaries. The median interval between surgery for the primary tumor and the discovery of a brain secondary was 27.5 months. The lung was the most common site of concurrent metastatic disease, with the discovery of a brain secondary a median of 9.7 months after diagnosis of the lung lesion. All patients were symptomatic. The majority of the patients received nonsurgical treatment for the brain lesion. Median survival after diagnosis of brain secondaries was 2.4 months.

Conclusions

The poor survival of the patients in our series could be due to late diagnosis. It may be recommended that a brain scan be performed to screen for a brain secondary when lung and/or liver metastases are discovered, especially in a patient with a left-sided cancer. This may lead to earlier diagnosis, amenability to surgical treatment, and improved survival and quality of life.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Seow A, Koh WP, Chia KS et al (2004) Trends in Cancer Incidence in Singapore 1968–2002. Singapore Cancer Registry Report No. 6

  2. Schouten LJ, Rutten J, Huveneers HA et al (2002) Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma. Cancer 94(10):2698–2705

    Article  PubMed  Google Scholar 

  3. Barnholtz-Sloan JS, Sloan AE, Davis FG et al (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22(14):2865–2872

    Article  PubMed  Google Scholar 

  4. Ko FC, Liu JM, Chen WS et al (1999) Risk and patterns of brain metastases in colorectal cancer: 27-year experience. Dis Colon Rectum 42(11):1467–1471

    Article  PubMed  CAS  Google Scholar 

  5. Alden TD, Gianino JW, Saclarides TJ (1996) Brain metastases from colorectal cancer. Dis Colon Rectum 39(5):541–545

    Article  PubMed  CAS  Google Scholar 

  6. Sundermeyer ML, Meropol NJ, Rogatko A et al (2005) Changing patterns of bone and brain metastases in patients with colorectal cancer. Clin Colorectal Cancer 5(2):108–113

    Article  PubMed  Google Scholar 

  7. Wronski M, Arbit E (1999) Resection of brain metastases from colorectal carcinoma in 73 patients. Cancer 85(8):1677–1685

    Article  PubMed  CAS  Google Scholar 

  8. Breneman JC, Warnick RE, Albright RE Jr et al (1997) Stereotactic radiosurgery for the treatment of brain metastases. Results of a single institution series. Cancer 79(3):551–557

    Article  PubMed  CAS  Google Scholar 

  9. Obrand DI, Gordon PH (1997) Incidence and patterns of recurrence following curative resection for colorectal carcinoma. Dis Colon Rectum 40(1):15–24

    Article  PubMed  CAS  Google Scholar 

  10. Sato H, Tsuchiya A, Nomizu T et al (1993) The neurosurgical management of brain metastasis from colorectal cancer: a report of three cases. Surg Today 23(7):639–643

    Article  PubMed  CAS  Google Scholar 

  11. Hammoud MA, McCutcheon IE, Elsouki R et al (1996) Colorectal carcinoma and brain metastasis: distribution, treatment, and survival. Ann Surg Oncol 3(5):453–463

    Article  PubMed  CAS  Google Scholar 

  12. Flickenger JC, Kondziolka D, Lunsford LD et al (1994) A multi-institutional experience with stereotactic radiosurgery for solitary brain metastasis. Int J Radiat Oncol Biol Phys 28:797–802

    Google Scholar 

  13. Auchter RM, Lamond JP, Alexander E et al (1996) A multi-institutional outcome and prognostic factor analysis of radiosurgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys 35(1):27–35

    PubMed  CAS  Google Scholar 

  14. Farnell GF, Buckner JC, Cascino TL et al (1996) Brain metastases from colorectal carcinoma The long term survivors. Cancer 78(4):711–716

    Article  PubMed  CAS  Google Scholar 

  15. Anthony T, Simmang C, Hyman N et al (2004) Practice parameters for the surveillance and follow-up of patients with colon and rectal cancer. Dis Colon Rectum 47(6):807–817

    Article  PubMed  Google Scholar 

  16. Engstrom PF, Arnoletti JP, Benson AB et al (2006) NCCN Clinical practice guidelines in oncology, v.2. Colon cancer and rectal cancer. National Comprehensive Cancer Network, Fort Washington, PA

    Google Scholar 

  17. Figueredo A, Rumble RB, Maroun J et al (2003) Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer 3:26

    Article  PubMed  Google Scholar 

  18. Desch CE, Benson AB 3rd, Somerfield MR et al (2005) Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology practice guideline. J Clin Oncol 23(33):8512–8519

    Article  PubMed  Google Scholar 

  19. Staib L, Schirrmeister H, Reske SN et al (2000) Is (18)F-fluorodeoxyglucose positron emission tomography in recurrent colorectal cancer a contribution to surgical decision making? Am J Surg 180(1):1–5

    Article  PubMed  CAS  Google Scholar 

  20. Swanson RS (2001) Is an FDG-PET scan the new imaging standard for colon cancer? Ann Surg Oncol 8(10):752–753

    Article  PubMed  CAS  Google Scholar 

  21. Fletcher JW, Djulbegovic B, Soares HP et al (2008) Recommendations on the use of 18F-FDG PET in oncology. J Nucl Med 49(3):480–508

    Article  PubMed  Google Scholar 

  22. Watson AJ, Lolohea S, Robertson GM et al (2007) The role of positron emission tomography in the management of recurrent colorectal cancer: a review. Dis Colon Rectum 50(1):102–114

    Article  PubMed  CAS  Google Scholar 

  23. Libutti SK, Alexander HR Jr, Choyke P et al (2001) A prospective study of 2-[18F] fluoro-2-deoxy-d-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels. Ann Surg Oncol 8(10):779–786

    Article  PubMed  CAS  Google Scholar 

  24. Dias AR, Nahas SC, Camargo EE et al (2007) Recent evidences of the use of 18F-fluorodeoxyglucose positron emission tomography in the management of colorectal cancer. J Surg Educ 64(2):114–119

    Article  PubMed  Google Scholar 

  25. Chen W (2007) Clinical applications of PET in brain tumors. J Nucl Med 48(9):1468–1481

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kok-Sun Ho.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tan, WS., Ho, KS. & Eu, KW. Brain Metastases in Colorectal Cancers. World J Surg 33, 817–821 (2009). https://doi.org/10.1007/s00268-009-9919-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-009-9919-3

Keywords

Navigation